Published in
SKIN The Journal of Cutaneous Medicine, (3), p. S35, 2019
Links
Tools
Bimekizumab provides rapid and sustained improvements in quality of life that correlate with clinical outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized , double blinded , Phase 2b extension study
Journal article published in 2019 by
Kim A. Papp,
Joseph F. Merola,
Alice B. Gottlieb,
Christopher Em Griffiths,
Kristina K. Harris,
Nancy Cross,
Luke Peterson,
Christopher Cioffi,
Andrew Blauvelt
Abstract
Abstract not available.